Oral tofacitinib for psoriasis: what happens with interrupted treatment?

Br J Dermatol. 2015 May;172(5):1194-5. doi: 10.1111/bjd.13766.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Dermatologic Agents / administration & dosage*
  • Female
  • Humans
  • Male
  • Piperidines / administration & dosage*
  • Protein Kinase Inhibitors / administration & dosage*
  • Psoriasis / drug therapy*
  • Pyrimidines / administration & dosage*
  • Pyrroles / administration & dosage*

Substances

  • Dermatologic Agents
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Pyrroles